A comparison of prognostic indices in diffuse large B-cell lymphoma within the UK NCRI R-CHOP 14 versus 21 phase III trial
Authors
Gleeson, MCounsell, N
Cunningham, D
Hawkes, E
Lawrie, A
Jack, A
Smith, P
Pocock, C
Ardeshna, M
Radford, John A
McMillan, A
Davies, J
Turner, D
Kruger, A
Johnson, P
Linch, C
Affiliation
University of WarwickIssue Date
2018
Metadata
Show full item recordCitation
Gleeson M, Counsell N, Cunningham D, Hawkes E, Lawrie A, Jack A, et al. A comparison of prognostic indices in diffuse large B-cell lymphoma within the UK NCRI R-CHOP 14 versus 21 phase III trial. Blood. 2018;132.Journal
BloodDOI
10.1182/blood-2018-99-111824Additional Links
https://dx.doi.org/10.1182/blood-2018-99-111824Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2018-99-111824